Chinese Journal of Dermatology ›› 2026, Vol. 59 ›› Issue (4): 333-342.doi: 10.35541/cjd.20250371

• Original Articles • Previous Articles     Next Articles

circ_0005062 targets FUS/PAK1 mRNA to induce inflammatory injury in human dermal papilla cells: a mechanistic study

pan huang1, 2,Bi-Ying Wang3,wanghaizhen   

  • Received:2025-07-01 Revised:2026-02-08 Online:2026-04-15 Published:2026-04-03
  • Contact: wanghaizhen E-mail:491476130@qq.com
  • Supported by:
    Project of Health Commission of Hunan Province;Hunan Provincial Clinical Medical Research Center for Traditional Chinese Medicine Dermatology

Abstract: 【Abstract】 Objective To investigate the targeting interaction between circ_0005062 and fused in sarcoma (FUS)/p21-activated kinase 1 (PAK1) mRNA, and to explore molecular mechanisms underlying inflammatory injury in human dermal papilla (HDP) cells via modulating the caspase-1 signaling pathway. Methods Hair follicle tissues were collected from 10 patients with androgenetic alopecia (AGA) and 10 healthy volunteers. Quantitative real-time polymerase chain reaction (qPCR) was performed to determine the expression of circ_0005062, enzyme-linked immunosorbent assay (ELISA) to detect levels of inflammatory cytokines interleukin (IL)-6, IL-1β, IL-18, and tumor necrosis factor-α (TNF-α) in the cell culture supernatant, and Western blot analysis to determine the protein expression of PAK1, cleaved caspase-1/caspase-1, and cleaved N-terminal gasdermin D (GSDMD)in these tissues. An in vitro HDP injury model was established by treating HDP cells with 100 μmol/L dihydrotestosterone (DHT) for 24 hours. Based on this model, circ_0005062-knockdown or PAK1-overexpression HDP cells were constructed. The experimental groups were designed as follows: a DHT group was treated with DHT; a sh-circ group and a sh-NC group were transfected with sh-circ_0005062 and control plasmids, respectively; a FUS group and a FUS-NC group were transfected with FUS overexpression plasmids and control plasmids, respectively; a PAK1 group and a PAK1-NC group were transfected with PAK1 overexpression plasmids and control plasmids, respectively; untreated HDP cells served as the control group. Cell viability was assessed using the MTT assay in the control group, DHT group, DHT + sh-NC group, and DHT + sh-circ group, qPCR was performed to determine the expression of circ_0005062, PAK1 mRNA, and caspase-1 mRNA, ELISA to detect the levels of IL-6, IL-1β, IL-18, and TNF-α in the cell culture supernatant, and Western blot analysis to determine the protein expression of PAK1, cleaved caspase-1/caspase-1, and cleaved N-terminal GSDMD. RNA immunoprecipitation (RIP) assay was conducted to assess the enrichment of circ_0005062 and PAK1 mRNA bound to FUS in cells from the control group, sh-circ group, and sh-NC group. In addition, qPCR was performed to determine the expression of circ_0005062, FUS mRNA, and PAK1 mRNA in the control group, sh-NC + FUS-NC group, sh-circ + FUS-NC group, and sh-circ + FUS group. Statistical analysis was performed using the two independent samples t-test or one-way analysis of variance, and multiple comparisons were conducted using the least significant difference-t test. Results In the clinical samples, the expression level of circ_0005062 in hair follicle tissues was significantly higher in patients with AGA than in healthy controls (2.21 ± 0.17 vs. 1.00 ± 0.03, t = 12.01, P < 0.001). In addition, the levels of IL-6, IL-1β, IL-18, and TNF-α, as well as the protein expression levels of PAK1, cleaved caspase-1/caspase-1, and cleaved N-terminal GSDMD, were all significantly higher in patients with AGA than in healthy controls (all P < 0.05). In the cell experiments, cell viability was significantly lower in the DHT group than in the control group, but significantly higher in the DHT + sh-circ group than in the DHT + sh-NC group (both P < 0.05); compared with the control group, the DHT group showed significantly increased expression levels of circ_0005062, PAK1 mRNA, caspase-1 mRNA, the inflammatory cytokines IL-6, IL-1β, IL-18, and TNF-α, as well as the proteins PAK1, cleaved caspase-1/caspase-1, and cleaved N-terminal GSDMD (all P < 0.05); however, an opposite trend was observed in the DHT + sh-circ group compared with the DHT + sh-NC group (all P < 0.05). RIP assays showed that FUS could bind to both circ_0005062 and PAK1 mRNA. After treatment with actinomycin D for 4 hours, the mRNA expression level of PAK1 was significantly lower in the sh-circ + FUS-NC group than in the control group and the sh-NC + FUS-NC group, whereas it was significantly higher in the sh-circ + FUS group than in the sh-circ + FUS-NC group (all P < 0.05). Compared with the DHT group, the DHT + sh-circ + PAK1-NC group showed significantly decreased expression levels of circ_0005062, PAK1 mRNA, caspase-1 mRNA, the inflammatory cytokines IL-6, IL-1β, IL-18, and TNF-α, as well as the proteins PAK1, cleaved caspase-1/caspase-1, and cleaved N-terminal GSDMD (all P < 0.05); however, an opposite trend was observed in the DHT + sh-circ + PAK1 group compared with the DHT + sh-circ + PAK1-NC group (all P < 0.05). In addition, the expression level of circ_0005062 was significantly higher in the DHT group than in the control group, but significantly lower in the DHT + sh-circ + PAK1-NC group than in the DHT group (both P < 0.05), and there was no significant difference between the DHT + sh-circ + PAK1 group and the DHT + sh-circ + PAK1-NC group (P > 0.05). Conclusion circ_0005062 may aggravate inflammatory injury in HDP cells by targeting the FUS/PAK1 axis and regulating caspase-1 expression, thereby inhibiting cell proliferation and promoting inflammatory responses.

Key words: RNA, circular, Human dermal papilla cells, circ_0005062, RNA-binding protein FUS, p21-Activated kinases, Caspase 1, Inflammatory injury, Androgenetic alopecia